Immunocompromised Patients with COVID-19 May Remain Infectious for Much Longer than Previously Thought

Clinical laboratory professionals should note that one case study describes a COVID-positive cancer patient shedding infectious particles for five months, which is much longer than expected Just when researchers start believing they understand COVID-19 infections, something happens that reveals there is still more to learn. These additional findings are relevant for clinical laboratory managers and pathologists because the new insights often may play a role in how SARS-CoV-2 results should be...

Aetna’s New Health Plan for Individuals in Kansas City Allows CVS Health Services at MinuteClinics, HealthHUBs and Pharmacies to Be Network Providers

What is not clear is how Aetna might engage independent clinical laboratories as in-network providers for this health insurance plan For years, Dark Daily and its sister publication The Dark Report have regularly predicted that the traditional fee-for-service reimbursement model of indemnity health insurance that requires beneficiaries to pay a co-pay is on the way out. What is not known is how the nation’s biggest health insurers plan to reinvent themselves, as value-based reimbursement for...

GAO Report Predicts 40% Growth in Home Care over Next 10 Years in a Trend That Has Ramifications for the Nation’s Clinical Laboratories

Healthcare policymakers continue to support the move from expensive hospitals to outpatient, ambulatory, and home health settings in ways that will change where and how medical laboratories collect lab specimens Clinical laboratories have adapted to many changes in the past decade and the increased demand for home healthcare is one of them. Thus, predictions from the US federal Government Accountability Office (GAO) that the number of home care jobs in the US will grow by 40% in the next 10...

Stanford Medicine Seroprevalence Study of Dialysis Patients Shows Fewer than One in 10 Adults Has Antibodies to COVID-19 Indicating Herd Immunity is Far Off

Researchers conducted antibody testing on ‘remainder plasma,’ which could inform strategies for ongoing SARS-CoV-2 clinical laboratory surveillance testing In a clever use of stored clinical laboratory specimens, researchers in California conducted a nationwide seroprevalence survey—serology testing to determine the number of people in a population that carry a specific disease—that used “remainder plasma” from dialysis patients to look for antibodies to the COVID-19 infection. They found...

NASA Develops the ‘E-Nose,’ a Handheld Breath Analyzer That Can Measure Multiple Biomarkers Used in Medical Laboratory Tests

Noninvasive diagnostic technology developed for space travelers and warfighters might eventually be used by clinical laboratories and physician office labs To solve the problem of how to perform clinical laboratory tests on astronauts living for months at a time in the International Space Station (ISS), researchers associated with the National Aeronautics and Space Administration (NASA) are developing diagnostic tests that use human breath as the specimen. Last month, the research team...

Fitbit Receives FDA Approval for a Wearable Device App That Detects Atrial Fibrillation

Many companies want to adapt consumer wearables to monitor health conditions, including biomarkers tested by medical laboratories Clinical laboratory managers know that wearable devices for monitoring biophysical functions or measuring biomarkers are becoming more complex and capable thanks to advances in miniaturization, informatics, software, and artificial intelligence machine learning that enable new functions to be developed and proved to be accurate. In September, Fitbit (NYSE:FIT), took...